, emulsions 5 liposomes 6 and magnatic nanoparticles [7] [8] [9] [10] and etc, are used to target specific areas in the body. Because of the unique characteristics of magnetic nanoparticles such as superparamagnetism, high coercivity, low Curie temperature, and high magnetic susceptibility have gained much scientific interest [11] [12] . Drugcarrying magnetic nanoparticles can be concentrated in cancer tissue by external magnetic fields 13 . Internalization of magnetic nanoparticles strongly depends upon the particle size. These applications require the magnetic nanoparticles in size smaller than 100 nm and a narrow particle size distribution. Larger particles with a diameter higher than 200 nm are easily isolated by the spleen and finally eliminated by the cells of the phagocyte system, thus it leads to a reduction of blood circulation times. Small particles with diameters less than 10 nm are rapidly removed through extravasations and renal clearance. Particles with a diameter ranging from 10 to 100 nm might be considered optimal for intravenous injection and have the most prolonged blood circulation time. These particles are small enough to evade the RES of the body as well as to penetrate small capillaries of the tissues and offer the most effective distribution in targeted tissues 14 . When the magnetic nanoparticles is used uncoated as drug carriers, they have lower performance because of some limitations in drug loading, retention time ,and release rates in the blood stream 15, 16 . Coated magnetic nanoparticles with silica, gold, or polymers 14 not only overcome these problems but also to avoid the formation of aggregates and provide functional groups (amines or carboxylic acid) for help in binding various biological ligands 17 . Types of polymeric surface coatings(organic and inorganic) have been used such as dextran, carboxymethylated dextran, carboxydextran, starch, arabinogalactan, glycosaminoglycan, sulfonated styrene-divinylbenzene, polyethylene glycol (PEG), polyvinyl alcohol (PVA), poloxamers, polyoxamines 14 , Polyvinylpyrrolidone-iodine 18 and chitosan 19 . The natural polymers are more important because these materials are more biocompatibility 14 . Silica shells are appropriate options to be employed as protective coatings on iron oxide nanoparticles thanks to their stability under aqueous conditions and ease of synthesis [20] . Trialkoxysilanes , bifunctional molecules ,entail a trialkoxy group that they are granted to modify the surface of nanoparticles . (3-Aminopropyl) triethoxysilane is intended to be done through the grafting of aminopropylsilane groups (-O) 3 Si-(CH 2 ) 3 -NH 2 via formation of covalent bonds which are bound to the particle surface and makes basic surface. Following prior step, it would be regarded as nanocarrier attracting acidic drugs resulted in an ionic interaction 21, 22 . Modified magnetic nanoparticles have been synthesized by two methods. In the first method, nanoparticles are coated during the synthesis that is in situ coatings 23 . The post-synthesis coating method consists of grafting the polymer on the magnetic particles once synthesized [24] [25] [26] [27] (polymeric surfactants). This paper provides a detailed study of the preparation iron oxide nanoparticles modified with APTES by post grafting method and the anti-inflammatory drug: (+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acidNaproxen and (RS) 2-(3-benzoylphenyl)-propionic acid -Ketoprofen were loaded onto them. The morphology/size and magnetization was determined for these nanoparticles using Field Emission Scanning Microscopy (FE-SEM), X-ray powder diffraction and VSM respectively. Fourier transform infrared spectroscopy was employed in order to identify the presence of APTES, ketoprofen and Naproxen drugs on Fe 3 o 4 nanoparticles surface. Hydrodynamic size of ketoprofen-APTESnanoparticles was designated by Dynamic light scattering (DLS).
MATERIALS AND METHODS

Reagents and materials
Ferric chloride hexahydrate (FeCl 3 , 6H 2 O), (3-aminopropyl) triethoxysilane (APTES), (+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid (Naproxen), and (RS) 2-(3-benzoylphenyl)-propionic acid (Ketoprofen) were obtained from Sigma-Aldrich. Iron (III) sulfate heptahydrate (FeSO 4 , 7H 2 O) and ammonium hydroxide 25 wt% were purchased Fluka (Buchs, Switzerland).
Synthesis of Fe 3 O 4 nanoparticles
Iron oxide magnetic nanoparticles were prepared by a conventional co-precipitation. In summary, Sodium hydroxide solutions (250 mL, 1M) were added to a three-neck round-bottomed flask under protection of argon flow. The solution was heated to 85°C. Then 12 ml of deionized water containing 4.04 g of Iron(III) nitrate and 1.39 g of Iron(III) sulfate (FeSO 4 ,7H 2 O) were added dropwise, while stirring vigorously until a black precipitate was formed. The mixture was kept at this condition for 1 h. To remove the remaining ions, the generated precipitate was centrifuged and washed at least three times until a pH value of 7 was achieved. The powder was dried at 60°C for 24 hours.
Modification of Fe 3 O 4 nanoparticles by (3-aminopropyl) triethoxysilane
The obtained magnetite nanoparticles powder (1 g) was dispersed in 150 mL ethanol/ water (volume ratio, 1:1) solution by sonication for 30 min. After that, (3-aminopropyl) triethoxysilane (APTES) (99%, 3 mL) were added to the mixture. Then resulting mixture was stirred under argon atmosphere and 40 0 c for 24 hours. The final product was separated from the solution and washed for 5 times by water, acetone and ethanol. The precipitated product (APTES-Fe 3 O 4 ) was dried at room temperature under vacuum.
Adsorption of naproxen and ketoprofen drugs on APTES-Fe 3 O 4 nano carrier's surface
2.0 g of APTES-Fe 3 O 4 introduced to 100 mL of 2-propanol solution containing drug (10 mg/ mL). The adsorption was carried out at room temperature for 24 h. After magnetic separation, drug nanocarriers were perfectly washed by 2-propanol solution and dried at room temperature (24 h). Figure 1 indicates a schematic of these approaches.
RESULTS AND DISCUSSION
Preparing of iron oxide nanoparticles was carried out by the co precipitation method in an aqueous medium, through reaction (1). If the nanoparticles are exposed in the presence of oxygen or air, might undergo oxidation to Fe(OH) 3 or as shown in reaction (2) 28 Iron oxide nanoparticles surface modified by the process Silanization. This reaction involves the covering of a surface iron oxide nanoparticles through self-assembly with (3-aminopropyl)-triethoxysilane molecules. During this reaction ,hydroxyl groups on the surface of iron oxide nanoparticles attack and replace ethoxy groups of APTES ,thus is formed a covalent -Si-O-Si-bond and amino propyl-terminated surface((see Figure1) . The surface coating of nanoparticles by APTES depends on experimental parameters such as reaction time, temperature and silane concentration. Interaction of ketoprofen and Naproxen drugs (carboxylic acid) with basic amino propyl-terminated surface of iron oxide nanoparticles is an ionic interaction. Rosenholm and Lindén 29 show that in polar solvents like 2-propanol used in this research was possible. 29 .
Fourier transforms infrared spectra Fig. 3 indicates the FTIR spectra of the naked Fe 3 O 4 and APTES -Fe 3 O 4 carrier before and after ketoprofen and naproxen drugs adsorption. The Sharp and revealing peak at around 580-594 cm -1 can be observed in (a), (b), (e), and (f) spectra is relates to the absorption peak Fe-O -Fe bond of Fe 3 O 4 nanoparticles. This peak appears for bulk Fe 3 O 4 at 570 and 575 cm -1 . This blue shift is a result of decrease in the size of iron oxide [33] [34] . APTES presence on the surface of Fe 3 o 4 nanoparticles is proven by the bands at 996 and 1126cm "1 that dedicated to the Si -O stretching vibrations and the broad band at 3401cm "1 that is assigned to the N-H stretching vibration (Fig 3b) 
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. The presence of the propyl group of APTES was confirmed by C-H stretching vibrations that appeared at 2862 cm -1 . Adsorption Of ketoprofen and naproxen drugs on APTES-Fe3O4 nanoparticles resulted in disappearance of the absorption band at 1720 and 1728 cm -1 (Fig. 3c and d ) characteristic to carbonyl stretching vibrations in carboxylic groups in adsorbed ketoprofen and naproxen drugs respectively and appearance of them characteristic bands at 1638 and 1630 cm -1 (Fig. 3g and h Fig. 3g and h) 
Field Emission Scanning Microscopy
The surface morphology of naked Fe 3 O 4 , APTES-Fe 3 O 4 , naproxen and ketoprofen -APTES- Fe 3 O 4 nanoparticles, was observed by scanning electron microscopy. Fig. 4(a -d) shows the FE-SEM images of these nanoparticles respectively. As shown in from these images, the formation of nanoparticles is nearly uniform and spherical shape with homogeneously dispersed. In other words, during the silanization reaction and drug loading, morphological properties of nanoparticles do not noticeably change.
Energy Dispersive X-ray Analysis (EDX)
The surface composition of naked Fe 3 O 4 , APTES-Fe 3 O 4 , naproxen and ketoprofen -APTESFe 3 O 4 nanoparticles was designated by energydispersive X-ray spectroscopy as shown in Figure  5 and table 2. The presence of iron and oxygen can be seen in all of the samples, with iron abundance more than oxygen. APTES presence on the surface of Fe 3 O 4 nanoparticles was proven by increase of percentage C and Si (b). Also Ketoprofen and naproxen drug adsorption on the surface of APTESFe 3 O 4 nanoparticles is confirmed by the increase in carbon atomic and weight percent.
Dynamic light scattering (DLS) diagrams
The size histogram of naproxen (a) and ketoprofen (b) -APTES-Fe 3 O 4 is shown in Fig. 6 . Particles size was further identified by Zetasizer using DLS. These figures suggest that more than 50% of the atoms have hydrodynamic size below 100 nm. In drug delivery systems, the entry of nanoparticles to target tissue strongly relies on the size of the particles. Particles with a diameter ranging from 10 to 100 nm might be considered optimal for intravenous injection and have the most prolonged blood circulation time 14 .
Vibrating scanning magnetometry (VSM)
The magnetic properties of naked iron oxide and naproxen-APTES-iron oxide nanoparticles were characterized by vibrating sample magnetometry. VSM graphs of these samples are presented in Fig. 7 . As it is obvious from this figure, naked iron oxide nanoparticles and drug-APTES-iron oxide nanoparticles have a hysteresis loop with zero coercivity and remanence values or super paramagnetic behaviors, super paramagnetism occurs when the particles sufficiently small so that thermal fluctuations can overcome the magnetic anisotropy. The saturation magnetization value of naked iron oxide and naproxen -APTES-iron oxide nanoparticles were found to be 55.4and 45.5 electromagnetic units per gram (emu/g) respectively. The reduction in saturation magnetization was likely due to the existence of APTES on surface of Fe 3 O 4 nanoparticles.
CONCLUSIONS
Iron oxide magnetic nanoparticles were prepared by a conventional co-precipitation and modified by (3-aminopropyl) triethoxysilane (APTES) .The modification of Fe 3 O 4 nanoparticles leads to the formation of nanocarriers with surface basic properties. Two anti-inflammatory drug: (+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acidNaproxen and (RS) 2-(3-benzoylphenyl)-propionic acid -Ketoprofen were loaded on the surface of nanocarriers The adsorption of drugs is due to ionic interactions between the amine functional group of APTES and the carboxylic group of drugs, that confirmed by Fourier transform infrared spectra. The most part of nanocarriers loaded with drug has size less than 100 nm and due to inherent magnatic characteristic(45.5 emu/g ) they are able to penetrate the target tissue in attended of external magnetic fields.
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